Sirona Biochem Corp (SBM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Sirona Biochem Corp (SBM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sirona Biochem Corp (SBM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Sirona Biochem Corp (SBM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
40 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops programs in various therapeutic such as diabetes and cancer. It also offers services to cosmeceuticals such as anti-aging and depigmenting agents, biological ingredients: inducers and adjuvant for biological development. Sirona Biochem offers products include sodium glucose transporter (SGLT) inhibitors, cancer antigen, skin brightener, depigmenting agent, anti-aging cosmetic ingredients, inducers and adjuvant. The company has its presence in Canada and France.

Sirona Biochem Corp (SBM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on maj

  
Source:
Document ID
GDPH211418D
Country
Industry
Ticker
SBM=CA
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Sirona Biochem Corp, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Sirona Biochem Corp, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Sirona Biochem Corp, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Sirona Biochem Corp, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Sirona Biochem Corp, Medical Devices Deals, 2010 to YTD 201691
Sirona Biochem Corp, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Sirona Biochem Corp, Pharmaceuticals &Healthcare, Deal Details1225
  Partnerships121
    Sirona Biochem Enters Into Licensing Agreement With Cincinnati Children's Hospital Medical Center121
    Sirona Biochem Enters into Research Agreement with University of British Columbia131
    Sirona Biochem Enters Into Joint Venture Agreement With Bloom Burton141
    Sirona Biochem Enters Into Agreement With Cincinnati Children's Hospital To Create Novel Skin Care Technology151
  Licensing Agreements161
    Sirona Biochem Expands Licensing Agreement with Valeant Pharma161
    Sirona Biochem Enters Into Licensing Agreement With Obagi Medical For TFC-849171
    Sirona Biochem Enters Into Licensing Agreement With Wanbang Biopharma For SGLT2 Inhibitor182
  Equity Offering201
    Sirona Biochem Raises USD0.6 Million in Private Placement of Units201
    Sirona Biochem Raises USD0.8 Million in Private Placement of Shares up on Exercise of Warrants211
    Sirona Biochem Raises USD0.94 Million in Private Placement of Shares upon Exercise of Warrants221
    Sirona Biochem Completes Private Placement Of Shares For US$1 Million231
    Sirona Biochem Announces Private Placement Of Units For US$5 Million241
    Sirona Biochem Completes Private Placement Of Units For US$1 Million252
    Sirona Biochem Completes Second Tranche Of Private Placement Of Units For US$0.38 Million272
    Sirona Biochem Completes Private Placement Of Units For US$1.41 Million291
    Sirona Biochem Completes Private Placement Of Its Units For US$2.32 Million302
    Sirona Biochem Completes Private Placement Of Its Common Stock321
    Sirona Biochem Completes Private Placement Of US$1 Million331
    Sirona Biochem Completes Private Placement Of US$0.19 Million341
  Acquisition351
    Sirona Biochem Acquires TFChem352
Sirona Biochem Corp - Key Competitors371
Key Employees381
Locations And Subsidiaries391
  Head Office391
Appendix401
  Methodology401
  About GlobalData401
  Contact Us401
  Disclaimer401

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Sirona Biochem Corp (SBM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sirona-Biochem-Corp-SBM-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7587>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Sirona Biochem Corp (SBM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sirona-Biochem-Corp-SBM-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7587>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research